Yōni.Fit received 510(k) clearance from the US Food and Drug Administration (FDA) in August 2024 following completion of a national clinical trial by Urogynecologists at Stanford, NYU, and Jefferson Health.
"Watkins-Conti is well positioned to deliver an innovative yet practical solution for the millions of women experiencing stress incontinence."
- Dr. Ash Bowen, Urologist, Chief of Surgery at OU Medical Center, Director of Robotic Urological Surgery, Assistant Professor of Urology at the University of Oklahoma Health Sciences Center
